Unknown PHASE1 INTERVENTIONAL 1-arm NCT03482817

Drug Cocktail Interaction Study of St. John's Wort Dry Extract Ze 117

Drug Cocktail Interaction Study to Investigate the Effect of St. John's Wort Dry Extract Ze 117 on Several Cytochrome P450 Enzymes and on Transporter P-Glycoprotein in Healthy Volunteers

Sponsor: Max Zeller Soehne AG

Conditions Drug Interaction Study

Interventions Probe drug cocktail Ze 117

Updated 6 times since 2018 Last updated: Mar 22, 2018 Started: Feb 5, 2018 Primary completion: May 17, 2018 Completion: Jun 23, 2018

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE1 trial investigates Drug Interaction Study and is currently ongoing. Max Zeller Soehne AG leads this study, which shows 6 recorded versions since 2018 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Unknown PHASE1
Jul 2024 — Sep 2024 [monthly]

Unknown PHASE1

Status: Unknown Status → Unknown
Jan 2021 — Jul 2024 [monthly]

Unknown Status PHASE1
Apr 2020 — Jan 2021 [monthly]

Unknown Status PHASE1

Status: Enrolling By Invitation → Unknown Status
Jun 2018 — Apr 2020 [monthly]

Enrolling By Invitation PHASE1

▶ Show 1 earlier version

Apr 2018 — Jun 2018 [monthly]

Enrolling By Invitation PHASE1

First recorded

Feb 2018

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Max Zeller Soehne AG

Data source: Max Zeller Soehne AG

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Neu-Ulm, Germany